Clinical trial
A Phase II Study of the Optune System, Enhanced by Genomic Analysis to Identify the Genetic Signature of Response in the Treatment of Recurrent Glioblastoma Multiforme
NCT01954576 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of the Optune System, Enhanced by Genomic Analysis to Identify the Genetic Signature of Response in the Treatment of Recurrent Glioblastoma Multiforme
- Lead sponsor
- University of Florida
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 10, 2013
- Completion date
- May 14, 2021
- Enrollment
- 21 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.